LAST CHANCE: Subscribe For Just ₹̶2̶9̶9̶9̶ ₹999
AstraZeneca Admits Its Covishield Vaccine Can Cause Rare Side Effects: Here's What They Are
SII Stopped Covishield Production In December 2021, No Takers For Booster Shots As People Are Fed Up: Poonawalla
As India Crosses 100 Crore Covid-19 Vaccinations, Here Are Four Things We Need To Realise
The First Quarter Billion Doses: Looking Back And Ahead
Bharat Biotech Calls Out ‘Covishield vs Covaxin’ Comparative Study, Adds That Report Had Lot Of Flaws
CoWIN App Reconfigured To Permit Online Bookings For 2nd Covishield Dose Only After 84 days
WHO Says B.1.617 Is Now ‘Variant of Concern’: What Do We Know So Far About Double Mutant Covid Variant
First Dose Of Oxford-Astrazeneca Covid-19 Vaccine Reduces Risk Of Death By 80 Per Cent: UK Study
Petition Filed In Bombay HC Seeking Z+ Security For SII CEO Adar Poonawalla, His Family
Govt Rubbishes Reports Claiming No New Vaccines Orders After March, Says Another 16 Crore Doses Ordered In April
As Covid-19 Cases Rise, Serum Institute Plans To Begin Overseas Production Of Covishield Vaccine: Report
US Dispatches Five Tonnes Of Oxygen Concentrators To India; More Consignments To Be Delivered Soon
Bullish Scenario For Vaccine Rollout: How India Might Achieve Herd Immunity By Dussehra
Seven More Covid-19 Vaccine Candidates In Clinical Trials: Dr Harsh Vardhan
AstraZeneca COVID-19 Vaccine Side Effects: India To Conduct Deeper Review After Suspension Of Use By Some Nations
After Trudeau’s Request, India In Principle Approves Supply Of Half-A-Million Covishield Vaccines To Canada
Pakistan To Receive ‘Made In India’ Covid19 Vaccines As Part Of Covax Global Alliance
PM Modi Likely To Be Vaccinated In Second Phase Of Covid-19 Immunisation Drive In March-April: Report
Serum Institute CEO Adar Poonawalla Takes Covid Vaccine To 'Endorse' Its Safety And Efficacy
Covaxin: Bharat Biotech Supplying 16.5 Lakh Doses Of Its Covid-19 Vaccine Free Of Cost To Government
